BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/17/2021 8:56:01 AM | Browse: 701 | Download: 1699
 |
Received |
|
2021-03-12 19:31 |
 |
Peer-Review Started |
|
2021-03-12 19:39 |
 |
First Decision by Editorial Office Director |
|
2021-05-01 16:26 |
 |
Return for Revision |
|
2021-05-01 16:26 |
 |
Revised |
|
2021-05-12 16:07 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-12-06 03:31 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-12-08 05:58 |
 |
Articles in Press |
|
2021-12-08 05:58 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2021-12-15 02:18 |
 |
Publish the Manuscript Online |
|
2021-12-17 08:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kunal Kapoor, Nour Eissa, Diane Tshikudi, Charles N Bernstein and Jean-Eric Ghia |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Crohn's and Colitis Canada |
P46601 |
| Canadian Foundation for Innovation |
P39902 |
| Children's Hospital Research Institute of Manitoba |
P45040 |
| Natural Sciences and Engineering Research Council |
P41224 |
| Manitoba Health Research Council |
P41118 |
|
| Corresponding Author |
Jean-Eric Ghia, AGAF, MSc, PhD, Associate Professor, Director, Director, Department of Immunology, University of Manitoba, 750 McDermot Ave, Apotex 431, Winnipeg R3E0T5, MB, Canada. jean-eric.ghia@umanitoba.ca |
| Key Words |
Chromofungin; Chromogranin-A; Colitis; Cytokines; Dendritic cells; Gut hormones |
| Core Tip |
Ulcerative colitis (UC) is characterized by a colonic decrease of chromofungin (CHR: chromogranin-A 47-66) and a dysregulation of CD11c+ dendritic cells (DC). Using a UC-like model (dextran sulphate sodium) and biopsies collected from UC patients, we demonstrated a protective effect of CHR via the regulation of DC-related markers and CD11c+ cells at the colonic, mesenteric lymph node and spleen levels, through a potential effect via the NF-κB pathway. In patients with active UC, CHR level showed a negative linear relationship with CD11c+ marker. CHR could be a potential therapy of UC, but larger samples and additional experiments are needed. |
| Publish Date |
2021-12-17 08:56 |
| Citation |
Kapoor K, Eissa N, Tshikudi D, Bernstein CN, Ghia JE. Impact of intrarectal chromofungin treatment on dendritic cells-related markers in different immune compartments in colonic inflammatory conditions. World J Gastroenterol 2021; 27(47): 8138-8155 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i47/8138.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i47.8138 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.